Ms Ashley Lauren Dees, OTR | |
933 19th St S, Room 308 P, Birmingham, AL 35205-3703 | |
(205) 975-0466 | |
Not Available |
Full Name | Ms Ashley Lauren Dees |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 933 19th St S, Birmingham, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386865491 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 2728 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Ashley Lauren Dees, OTR 933 19th St S, Room 308 P, Birmingham, AL 35205-3703 Ph: (205) 975-0466 | Ms Ashley Lauren Dees, OTR 933 19th St S, Room 308 P, Birmingham, AL 35205-3703 Ph: (205) 975-0466 |
News Archive
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced the closing of a private financing by the existing investors of Quark totaling an aggregate of $10 million. The investors are funds of the prestigious SBI Holdings Group in Japan. In connection with the financing, Mr. Yoshitaka Kitao, CEO of SBI Holdings, Inc. and Mr. Robert Takeuchi, Director of SBI Investment Co., Ltd. will become members of the Quark board of directors.
Regis Corporation would like to thank their stylists, customers and business partners, who together helped raise over $1 million for the Regis Foundation for Breast Cancer Research during their annual October Clip for the Cure event. Regis Corporation, the global leader in beauty salons, hair restoration centers and cosmetology education, has been supporting the cause since 1990.
Now that the Supreme Court has remanded Association for Molecular Pathology et al. v. Myriad Genetics, Inc., et al. (AMP v. Myriad) to the Court of Appeals for the Federal Circuit for further consideration, AMP is optimistic that it will ultimately prevail in its lawsuit to invalidate patents on two genes that are known to cause breast cancer.
Sucampo Pharmaceuticals, Inc. today announced that the Company received a supplement approval from the U.S. Food and Drug Administration (FDA) that removes pregnancy "warnings and precautions" and clarifies information regarding the use of AMITIZA (lubiprostone) by pregnant and/or nursing women. In addition, the FDA expanded the labeling text of the Mechanism of Action section in the prescribing information for AMITIZA.
› Verified 2 days ago
Mccall Henger Christenson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 5th Ave S, Birmingham, AL 35233 Phone: 205-939-9100 | |
Joseph Chase Bennett, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 South 19th Street, 8305a - Office, Birmingham, AL 35233 Phone: 205-933-8101 | |
Lynn Paige Larkey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 7th Ave S, Pt/ot Dept 4nw, Birmingham, AL 35233 Phone: 205-939-9645 Fax: 205-939-6067 | |
Mrs. Margiean Bridget Burks, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 5th Ave S, Birmingham, AL 35233 Phone: 205-939-6296 Fax: 205-558-2077 | |
Candace C Davis, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 930 20th St S, Suite 101, Birmingham, AL 35205 Phone: 205-934-5471 Fax: 205-975-2380 | |
Mrs. Anne Nehlig Walker, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4778 Overton Rd, Birmingham, AL 35210 Phone: 205-957-0294 Fax: 205-957-0298 | |
Anna Layne Wood, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4778 Overton Rd, Birmingham, AL 35210 Phone: 205-957-0294 Fax: 205-957-0298 |